Your browser doesn't support javascript.
loading
A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies.
Härkönen, Jouni; Pölönen, Petri; Deen, Ashik Jawahar; Selvarajan, Ilakya; Teppo, Hanna-Riikka; Dimova, Elitsa Y; Kietzmann, Thomas; Ahtiainen, Maarit; Väyrynen, Juha P; Väyrynen, Sara A; Elomaa, Hanna; Tynkkynen, Niko; Eklund, Tiia; Kuopio, Teijo; Talvitie, Eva-Maria; Taimen, Pekka; Kallajoki, Markku; Kaikkonen, Minna U; Heinäniemi, Merja; Levonen, Anna-Liisa.
Afiliação
  • Härkönen J; Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, 70210, Finland; Department of Pathology, Hospital Nova of Central Finland, Jyväskylä, 40620, Finland.
  • Pölönen P; Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, 70210, Finland; Faculty of Health Sciences, Institute of Biomedicine, University of Eastern Finland, Kuopio, 70210, Finland.
  • Deen AJ; Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, 70210, Finland.
  • Selvarajan I; Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, 70210, Finland.
  • Teppo HR; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, 90220, Finland; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, 90570, Finland; Department of Pathology, Oulu University Hospital, Oulu, 90220, Finland.
  • Dimova EY; Faculty of Biochemistry and Molecular Medicine, University of Oulu and Biocenter Oulu, Oulu, 90570, Finland.
  • Kietzmann T; Faculty of Biochemistry and Molecular Medicine, University of Oulu and Biocenter Oulu, Oulu, 90570, Finland.
  • Ahtiainen M; Department of Education and Research, Hospital Nova of Central Finland, Jyväskylä, 40620, Finland.
  • Väyrynen JP; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, 90220, Finland; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, 90570, Finland; Department of Pathology, Oulu University Hospital, Oulu, 90220, Finland.
  • Väyrynen SA; Department of Internal Medicine, Oulu University Hospital, Oulu, 90220, Finland.
  • Elomaa H; Department of Education and Research, Hospital Nova of Central Finland, Jyväskylä, 40620, Finland; Department of Biological and Environmental Science, University of Jyväskylä, Jyväskylä, 40100, Finland.
  • Tynkkynen N; Gerontology Research Center (GEREC), Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, 40014, Finland.
  • Eklund T; Department of Biological and Environmental Science, University of Jyväskylä, Jyväskylä, 40100, Finland.
  • Kuopio T; Department of Pathology, Hospital Nova of Central Finland, Jyväskylä, 40620, Finland; Department of Biological and Environmental Science, University of Jyväskylä, Jyväskylä, 40100, Finland.
  • Talvitie EM; Department of Genomics, Turku University Hospital and University of Turku, Turku, 20520, Finland.
  • Taimen P; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, 20520, Finland; Department of Pathology, Turku University Hospital, Turku, 20521, Finland.
  • Kallajoki M; Department of Pathology, Turku University Hospital, Turku, 20521, Finland.
  • Kaikkonen MU; Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, 70210, Finland.
  • Heinäniemi M; Faculty of Health Sciences, Institute of Biomedicine, University of Eastern Finland, Kuopio, 70210, Finland.
  • Levonen AL; Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, 70210, Finland. Electronic address: anna-liisa.levonen@uef.fi.
Redox Biol ; 61: 102644, 2023 05.
Article em En | MEDLINE | ID: mdl-36867945
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Fator 2 Relacionado a NF-E2 Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Redox Biol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Fator 2 Relacionado a NF-E2 Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Redox Biol Ano de publicação: 2023 Tipo de documento: Article